PACS Group CEO Hulse sells $5.6m in PACS stock
PACS Group CEO Hulse sells $5.6m in PACS stock
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
PACS Group CEO Hulse sells $5.6m in PACS stock
Teacher tackled and fought Oregon school shooter
Ethos Technologies CEO sells over $4.6m in company stock
Ethos Technologies president Wang Lingke sells $4.5m in LIFE shares
Sonic Automotive director Paul Rusnak buys $752,044 in stock
Actor Selma Blair did not intend harm on flight, spokesperson says
Copper Lake Resources closes $5M private placement
US lifts restrictions on new Mexican flights from capital’s airports
Rystad Energy’s fifth edition of its flagship annual report, Global Energy Scenarios (GES) 2026, finds that global reliance on imported energy is projected to peak by 2034 as energy security concerns accelerate the shift towards electrification. Against the backdrop of two major energy crises in five years, the report highlights how a broader range of rapidly deployable technologies is helping…
The software and semiconductor sectors haven’t been trading in tandem much this year, but they collectively fell Friday as AI and interest-rate fears hit the market.
Grynspan holds lead for next UN chief as race enters decisive stage
Money is pouring in and funding intense, negative ads: “It’s everywhere, and you can’t escape it.”
Gabriel Resources closes initial C$3.29M private placement
EQB appoints Vivian Abdelmessih to board of directors
LA restaurant group used $60,000 Dodgers bet to hedge playoff risk, Kalshi says
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock
MapLight Therapeutics chief scientific officer sells $93,025 in shares
MapLight Therapeutics CAO sells $82,149 in shares
MapLight Therapeutics general counsel reports $72,881 stock sale
News text belongs to its source; only the headline and a short summary appear here.